A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial ...

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab Induction Therapy Followed by Multiple Regimens of Maintenance Infliximab Therapy in Subjects with Plaque-type Psoriasis 1% effort 3 subjects

Awarded By

  • Centocor

Contributors

Amount

  • $73,125.00

Start/End

  • December 19, 2003 - December 30, 2005